/stocks — the workspaceLOADING
All CHSCN SEC filings, by type → · Earnings date & implied move · Search inside filings
CHS INC (CHSCN) is a wholesale-farm product raw materials company. Piotroski F-Score 4/8. Next earnings projected around 2026-11-04 from CHSCN's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind CHSCN’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
FY ending 2025-08-31 vs 2024-08-31.
No sensitivity grid: free cash flow is not positive, so the DCF gives no value at any growth or discount rate.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from CHSCN’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on CHSCN plus an auto-SWOT — built from CHSCN's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate CHSCN using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has CHSCN been issuing shares? Offering history →
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as CHSCN tagged it: revenue us-gaap:Revenues, net income us-gaap:NetIncomeLoss, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
No lawmaker has disclosed a trade in CHSCN under the STOCK Act.
Projected from CHSCN's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentCHSCN files or announces.
CHSCN's earnings reaction has been evenly split — 4 up, 4 down across its last 8 reports.
Each figure is one earnings reaction — how much CHSCN moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Earnings reactions have been mild.
The average is inflated by its most volatile prints (+0.7% and -0.9%).
A more typical earnings reaction has been approximately ±0.2%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-07-08 | +0.7% |
| 2026-04-08 | +0.1% |
| 2026-01-07 | -0.2% |
| 2025-11-05 | +0.0% |
| 2025-07-09 | +0.2% |
| 2025-04-02 | -0.2% |
| 2025-01-08 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -0.7% |
| 2024-11-06 | -0.9% |
No tracked institution reported a position in CHSCN in the latest 13F round.
None of the 5 estimators could run on CHSCN's filings.
One estimator is a point estimate, not a range, so no band and no valuation label are published for CHSCN. Below is everything that was checked, so the refusal can be read rather than taken on trust.
Nothing produced a value.
No fiscal year of price history was on record; the historical multiples need 5. No sector peer set is priced for CHSCN, so sector medians could not fill the gaps.
Every refusal recorded for CHSCN → · How often we decline, and why →
Shareholder returns exceeded free cash flow this period — the difference was funded from cash on hand, debt, or asset sales rather than the business itself. Common and sustainable for a period; worth watching if it persists.
Every figure is from CHSCN’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.
No open-market Form 4 buys or sells reported for CHSCN in the last ~6 months.
2 of the 2 checks that ran found nothing new for CHSCN. 2 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
Head office: Inver Grove Heights, Minnesota, United States
Source: the cover page of CHS INC’s 10-Q filed 2026-07-08, on EDGAR. Filings checked 2026-10-25. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works